Rita Laeufle (IMAGE)

ECOG-ACRIN Cancer Research Group

Rita Laeufle

Caption

Rita Laeufle is chief medical officer at Oncolytics Biotech, Inc. developing peloreorep, an IV-delivered immuno-oncolytic virus, and collaborating with PrECOG, LLC on the BRACELET-1 (PrE0113) clinical trial that will evaluate peloreorep in metastatic breast cancer.

Credit

Supplied by Oncolytics Biotech, Inc.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.